Effect of pulmonary artery pressure‐guided therapy on heart failure readmission in a nationally representative cohort

AIMS: Pulmonary artery pressure (PAP)‐guided therapy in patients with heart failure (HF) using the CardioMEMS (CMM) device, an implantable PAP sensor, has been shown to reduce HF hospitalizations in previous studies. We sought to evaluate the clinical benefit of the CMM device in regard to 30, 90, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kishino, Yoshikazu, Kuno, Toshiki, Malik, Aaqib H., Lanier, Gregg M., Sims, Daniel B., Ruiz Duque, Ernesto, Briasoulis, Alexandros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288808/
https://www.ncbi.nlm.nih.gov/pubmed/35560987
http://dx.doi.org/10.1002/ehf2.13956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288808/
https://www.ncbi.nlm.nih.gov/pubmed/35560987
http://dx.doi.org/10.1002/ehf2.13956

Ejemplares similares